Detalhe da pesquisa
1.
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.
N Engl J Med
; 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38820078
2.
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia.
N Engl J Med
; 388(4): 319-332, 2023 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36511784
3.
Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia.
N Engl J Med
; 386(15): 1421-1431, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35417637
4.
Upper and/or Lower Respiratory Tract Infection Caused by Human Metapneumovirus After Allogeneic Hematopoietic Stem Cell Transplantation.
J Infect Dis
; 229(1): 83-94, 2024 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37440459
5.
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options.
Ann Hematol
; 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38438627
6.
Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience.
Ann Hematol
; 103(2): 451-461, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38110588
7.
De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors.
Am J Hematol
; 99(4): 763-766, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38317312
8.
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia.
Am J Hematol
; 99(4): 615-624, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38343151
9.
Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatment.
Future Oncol
; 20(12): 717-726, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38088119
10.
Expansions of tumor-reactive Vdelta1 gamma-delta T cells in newly diagnosed patients with chronic myeloid leukemia.
Cancer Immunol Immunother
; 72(5): 1209-1224, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36376516
11.
Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options.
Blood
; 138(25): 2670-2685, 2021 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33945616
12.
FoxO1-GAB1 axis regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia.
Blood
; 138(9): 758-772, 2021 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33786575
13.
miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors.
Blood
; 137(18): 2481-2494, 2021 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33171493
14.
Low incidence of severe acute and chronic graft-versus-host disease in a long-term retrospective study with ATG Grafalon routine use.
Ann Hematol
; 102(12): 3587-3591, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37783854
15.
Low levels of minimal residual disease after induction chemotherapy for BCR-ABL1-negative acute lymphoblastic leukaemia in adults are clinically relevant.
Br J Haematol
; 196(3): 706-710, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34816424
16.
Successful early use of anti-SARS-CoV-2 monoclonal neutralizing antibodies in SARS-CoV-2 infected hematological patients - A Czech multicenter experience.
Hematol Oncol
; 40(2): 280-286, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35120267
17.
BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph+ chronic myeloid leukemia.
Am J Hematol
; 97(9): 1215-1225, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35794848
18.
Effective NPM1 plasmid standards selection for minimal/measurable residual disease monitoring in acute myeloid leukemia.
Mol Biol Rep
; 49(8): 8169-8172, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35716280
19.
Design of the VIALE-M phase III trial of venetoclax and oral azacitidine maintenance therapy in acute myeloid leukemia.
Future Oncol
; 18(26): 2879-2889, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35852098
20.
Hierarchical distribution of somatic variants in newly diagnosed chronic myeloid leukaemia at diagnosis and early follow-up.
Br J Haematol
; 194(3): 604-612, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34212373